| 2024-10 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study |
Oncologist. 2024 Oct 3;29(10):e1396-e1405. |
 |
| 2024-07-11 |
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study |
BMC Cancer. 2024 Jul 11;24:Article number 828. |
|
| 2024-04-27 |
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: Clinical and prognostic correlations |
Annals of Hematology. 2024 Apr 27;Article in Press. |
|
| 2024-02-13 |
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan |
Journal of Biomedical Science. 2024 Feb 13;31:Article number 21. |
|
| 2023-10 |
Risk of type 2 diabetes mellitus and hyperlipidemia in patients with chronic myeloid leukemia initiating tyrosine kinase inhibitors: A nationwide cohort study |
Pharmacoepidemiology and Drug Safety. 2023 Oct;32(Suppl. S1):575. |
|
| 2023-01 |
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway |
Cancer Medicine. 2023 Jan;12(2):1588-1601. |
|
| 2022-12-28 |
Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan |
Scientific Reports. 2022 Dec 28;12:Article number 22492. |
|
| 2022-11-06 |
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation |
Journal of Biomedical Science. 2022 Nov 06;29:Article number 92. |
|
| 2022-09 |
Multi-kinase inhibitors for the treatment of asymptomatic radioactive Iodine-refractory differentiated thyroid cancer: Global non-interventional study (RIFTOS MKI) |
Thyroid. 2022 Sep;32(9):1059-1068. |
|
| 2022-07 |
Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience |
Annals of Oncology. 2022 Jul;33(Suppl. 6):S535. |
|
| 2022-05-15 |
Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience |
American Journal of Cancer Research. 2022 May 15;12(5):2189-2202. |
|
| 2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors |
Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660. |
|
| 2021-11-30 |
Survival outcomes of management in metastatic gastric adenocarcinoma patients |
Scientific Reports. 2021 Nov 30;11:Article number 23142. |
|
| 2021-11-12 |
The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience |
Frontiers in Oncology. 2021 Nov 12;11:Article number 741096. |
|
| 2021-09 |
Anaplastic thyroid cancer successfully treated with radiation and immunotherapy: A case report |
AACE Clinical Case Reports. 2021 Sep;7(5):299-302. |
|
| 2021-07-20 |
Cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors in Taiwan: A nationwide population-based study |
European Journal of Preventive Cardiology. 2021 Jul 20;29(9):1312-1321. |
|
| 2021-07-15 |
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol |
Scientific Reports. 2021 Jul 15;11:Article number 14567. |
|
| 2021-05 |
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia |
Cancer Medicine. 2021 May;10(9):2946-2955. |
|
| 2021-04-12 |
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan |
Scientific Reports. 2021 Apr 12;11:Article number 7881. |
|
| 2021-04 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors |
Oncologist. 2021 Apr;26(4):e567-e579. |
|
| 2021-03-01 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors |
Scientific Reports. 2021 Mar 1;11:Article number 4834. |
|
| 2021-03 |
Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-kappa B/IL-6/ROS signaling |
Journal of Experimental and Clinical Cancer Research. 2021 Mar;40:Article number 95. |
|
| 2021-02 |
IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NF kappa B/IL-6/ROS signaling |
Cancer Science. 2021 Feb;112(Suppl. 1):776. |
|
| 2021-01 |
Experience of sorafenib treatment in differentiated thyroid cancer from Taiwan |
Journal of the Formosan Medical Association. 2021 Jan;120(1,Pt 1):189-195. |
|
| 2021-01 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation |
Cancer Science. 2021 Jan;112(1):243-253. |
|
| 2020-11-13 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.] |
Scientific Reports. 2020 Nov 13;10:Article number 20199. |
|
| 2020-07-01 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue |
Haematologica. 2020 Jul 1;105(7):e349-e354. |
|
| 2020-05-26 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan |
Journal of Biomedical Science. 2020 May 26;27:Article number 69. |
|
| 2020-05-04 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort |
Scientific Reports. 2020 May 4;10:Article number 7420. |
|
| 2020-05 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas |
Oncologist. 2020 May;25(5):e782-e788. |
|
| 2019-12 |
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia |
Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150. |
|
| 2019-10 |
The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan |
Cancer Epidemiology, Biomarkers and Prevention. 2019 Oct;28(10):1694-1703. |
|
| 2019-09-10 |
Environmental risk factors of pancreatic cancer |
Journal of Clinical Medicine. 2019 Sep 10;8(9):Article number 1427. |
|
| 2019-04-10 |
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants |
Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957. |
|
| 2018-12 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation |
Cancer Science. 2018 Dec;109(Suppl. 2):866. |
|
| 2018-12 |
The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan |
Cancer Science. 2018 Dec;109(Suppl. 2):1437. |
|
| 2018-11 |
The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan |
Cancer Medicine. 2018 Nov;7(11):5775-5788. |
|
| 2018-08-24 |
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor |
Cancer Science. 2018 Nov;109(11):3591-3601. |
|
| 2018-08 |
Stem cell transplantation for T-cell lymphomas in Taiwan |
Bone Marrow Transplantation. 2018 Aug;53(8):993-1000. |
|
| 2018-01 |
The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors |
Cancer Science. 2018 Jan;109(Suppl. 1):466. |
|
| 2017-10-09 |
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors |
Oncotarget. 2017 Oct 09;8(61):103613-103625. |
|
| 2017-09-16 |
The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors |
Oncotarget. 2017 Sep 16;8(58):98068-98083. |
|
| 2017-09 |
A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients |
Scientific Reports. 2017 Sep;7:Article number 11253. |
|
| 2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy |
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531. |
|
| 2017-02 |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21) |
Journal of Pathology. 2017 Feb;241(3):420-433. |
|
| 2016-12 |
Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST |
Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 2P. |
|
| 2016-10 |
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia |
Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333. |
|
| 2016-10 |
CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma |
Annals of Oncology. 2016 Oct;27(Suppl. 6):Meeting Abstract 933P. |
|
| 2016-08-31 |
The oncometabolite R-2-hydroxyglutarate activates NF-kappa B-dependent tumor-promoting stromal niche for acute myeloid leukemia cells |
Scientific Reports. 2016 Aug 31;6:Article number 32428. |
|
| 2016-05 |
Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma |
Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e19024. |
|
